PNC FINANCIAL SERVICES GROUP, INC. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 105 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$2,0000.0%3920.0%0.00%
Q4 2021$2,0000.0%3920.0%0.00%
Q3 2021$2,0000.0%3920.0%0.00%
Q2 2021$2,0000.0%392
+79.8%
0.00%
Q1 2021$2,0000.0%2180.0%0.00%
Q4 2020$2,0002180.0%0.00%
Q3 2020$02180.0%0.00%
Q2 2020$0218
-4.0%
0.00%
Q1 2020$0227
-23.8%
0.00%
Q4 2019$0
-100.0%
298
+30.7%
0.00%
Q3 2019$1,000228
+103.6%
0.00%
Q2 2019$0112
-19.4%
0.00%
Q1 2019$0139
+6.9%
0.00%
Q4 2018$0
-100.0%
130
+16.1%
0.00%
Q3 2018$2,0000.0%1120.0%0.00%
Q2 2018$2,000
-83.3%
112
-88.7%
0.00%
Q1 2018$12,000
-25.0%
992
+6.4%
0.00%
Q4 2017$16,000
-27.3%
932
+5.9%
0.00%
Q3 2017$22,0000.0%8800.0%0.00%
Q2 2017$22,0008800.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$16,279,0002.44%
Abingworth LLP 1,041,131$6,517,0002.23%
Telemetry Investments, L.L.C. 194,789$1,219,0002.06%
AIGH Capital Management LLC 749,608$4,692,0001.91%
Trellus Management Company, LLC 340,000$2,128,0001.76%
Bruce & Co., Inc. 929,312$5,817,0001.12%
Worth Venture Partners, LLC 191,093$1,196,0000.95%
GENERAL AMERICAN INVESTORS CO INC 1,000,751$6,265,0000.62%
Weil Company, Inc. 104,907$657,0000.39%
NEXPOINT ASSET MANAGEMENT, L.P. 140,020$877,0000.29%
View complete list of PARATEK PHARMACEUTICALS INC shareholders